PinkDx, Inc.

📍 San Francisco, United States🗓 Founded 2022👥 22 employees💰 Last funded Jan 2025
Medical and Diagnostic Laboratories🌐 pinkdx.com
Website LinkedIn
PinkDx is an early-stage company whose vision is to positively impact the health of women throughout their life journey. We focus on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and provide answers that have an immediate, positive impact on their lives. Our first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer. Led by a team of diagnostics industry veterans, PinkDx is privately held, with funding from prominent biotechnology investors, including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital and Mayo Clinic.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in PinkDx, Inc.?
PinkDx, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did PinkDx, Inc. last raise funding?
The most recent investment in PinkDx, Inc. recorded on gritt.io was in January 2025.
When was PinkDx, Inc. founded?
PinkDx, Inc. was founded in 2022.
What industry is PinkDx, Inc. in?
PinkDx, Inc. operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is PinkDx, Inc. based?
PinkDx, Inc. is headquartered in San Francisco, United States.